Parkland Community Health Plan policy updates
Track new and updated Parkland Community Health Plan policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Updated Prior Authorization Criteria for Lisocabtagene Maraleucel (Breyanzi) | Parklandcommunityhealthplan | Clinical | Pharmacy & Specialty Drugs | Modified | Dec 1, 2026 |
| Provider Guidelines for Durable Medical Equipment (DME) and Supplies | Parklandcommunityhealthplan | Clinical | Durable Medical Equipment (DME) | Modified | Oct 21, 2026 |
| MRI Imaging for Suspected Placenta Accreta | Parklandcommunityhealthplan | Clinical | Radiology/Diagnostic Imaging | Modified | Oct 16, 2026 |
| MRI Imaging for Suspected Placenta Accreta | Parklandcommunityhealthplan | Clinical | Radiology/Diagnostic Imaging | Modified | Oct 11, 2026 |
| Cranial Remolding Orthosis (CRO) Benefit Criteria | Parklandcommunityhealthplan | Clinical | Prosthetics & Orthotics | Modified | Sep 1, 2026 |
| Medical Necessity Determination and Appeal Overturn Policy for Off-Label Use of Farxiga (Dapagliflozin) in Pediatric Members with Heart Failure and Complex Cardiac Conditions | Parklandcommunityhealthplan | Clinical | Cardiology | Modified | Jun 26, 2026 |
| Medical Necessity Determination and Appeal Overturn Policy for Off-Label Inhaled Tobramycin Use in Pediatric Members <6 Years of Age with Cystic Fibrosis | Parklandcommunityhealthplan | Clinical | Pharmacy & Specialty Drugs | Modified | Jun 26, 2026 |
| Clinical Policy: Biosimilar-First Coverage for Clinician-Administered Drugs | Parklandcommunityhealthplan | Clinical | Pharmacy & Specialty Drugs | Modified | Jun 6, 2026 |
| Rituximab (Rituxan) Off-Label Therapy Coverage Criteria | Parklandcommunityhealthplan | Clinical | Pharmacy & Specialty Drugs | Modified | Jan 1, 2026 |
| Psychiatric Diagnostic Evaluations | Parklandcommunityhealthplan | Clinical | Psychiatry/Behavioral Health | Modified | Jan 1, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.